These results suggest that the increase in E-selectin binding molecules on AML relapse cells increases the ability of the relapse cells to exit circulation faster and demonstrates that inhibiting E-selectin binding can prevent CLCs from rapidly leaving circulation. The gene discussed is SELE; the disease is acute myeloid leukemia.